Structure Therapeutics Inc. ADR (GPCR) Social Stream



Structure Therapeutics Inc. ADR (GPCR): $47.52

1.06 (-2.18%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

STRUCTURE THERAPEUTICS INC (GPCR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering GPCR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2023-02-28 4 $34 $33 $33.5 $45.37 -26.16%
2023-04-04 4 $50 $33 $39.25 $45.37 -13.49%
2023-05-25 4 $50 $33 $41 $45.37 -9.63%
2023-06-26 4 $50 $40 $44.25 $45.37 -2.47%
2023-06-29 4 $50 $40 $46.5 $45.37 2.49%
2023-09-19 5 $58 $40 $48.8 $45.37 7.56%
2023-09-29 5 $97 $40 $64.8 $45.37 42.83%
2023-10-12 5 $97 $58 $81.8 $45.37 80.3%
2023-10-28 6 $97 $79 $89 $45.37 96.16%
2023-11-15 6 $97 $79 $89.166 $45.37 96.53%
2023-12-18 6 $93 $58 $82.666 $45.37 82.2%
NA 2 $NA $NA $NA $45.37 NA%

The Trend in the Analyst Price Target


GPCR's average price target has moved up $43.42 over the prior 42 weeks.

Over the past 42 weeks, GPCR's average upside potential has been 47.68%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-04 4 50 33 39.25 24.72 58.78%
2023-05-25 4 50 33 41.00 29.10 40.89%
2023-08-10 5 58 40 48.80 29.35 66.27%
2023-10-03 5 97 58 81.80 58.94 38.79%
2023-10-28 6 97 79 89.00 68.17 30.56%

GPCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 43 weeks, GPCR's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GPCR as an investment opportunity.

  • GPCR has a higher number of analysts covering the stock than 240.61% of all US stocks.
  • STRUCTURE THERAPEUTICS INC's variance in analysts' estimates is lower than -171.11% of Pharmaceutical Products stocks.
  • GPCR has a greater upside potential (average analyst target price relative to current price) than 553.14% of stocks in the mid market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, STRUCTURE THERAPEUTICS INC's average analyst price target is higher than 869.14% of them.

Stocks similar to STRUCTURE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PASG, BDTX, and JSPR.

What is the outlook for GPCR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!